5'-ectonucleotidase in chronic lymphocytic leukemia [letter]

NLM AIDSLINE 5'-Ectonucleotidase in chronic lymphocytic leukemia [letter] Chalmers AH
July 30, 1999

Clin Biochem. 1999 Feb;32(1):91. Unique Identifier : AIDSLINE LETTER JOURNAL ARTICLE Antioxidants/METABOLISM Human HIV/METABOLISM Leukemia, Lymphocytic, Chronic/ENZYMOLOGY Reactive Oxygen Species/METABOLISM Stress/METABOLISM 5'-Nucleotidase/METABOLISM

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 NORTH DAKOTA: Officials: 26 Tuberculosis Cases from Grand Forks Outbreak AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common CANADA: Nunavut Uses Comic Book to Do Sex Education NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing UNITED STATES: Hepatitis C Testing for People Born Between 1945 and 1965 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV Experimental Gilead drug effective in early-stage leukemia trial TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events Gilead Receives Complete Response Letters from U.S. Food and Drug Administration for Elvitegravir and Cobicistat EUROPE: EU Expands Use of Roche's Pegasys in Chronic Hepatitis C UNITED STATES: Moderate, Excessive or Heavy Alcohol Consumption: Each is Significantly Associated with Increased Mortality in Patients with Chronic Hepatitis C India: HRW Letter to Justice Verma, Chair of the Commission on reforms on sexual assault and Former Chief Justice of the Supreme Court of India Chronic fatigue patients frustrated with FDA Reprogrammed HIV fights leukemia in child US doctors defeat leukemia with modified HIV HIV/AIDS Qualifies As 'Chronic Condition' Under Affordable Care Act, Scoring Major Victory in Fight Against HIV/AIDS
Information in this article was accurate in July 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.